Revolution Medicines (RVMD) Earnings Date, Estimates & Call Transcripts $38.17 -0.20 (-0.51%) As of 01:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Revolution Medicines Earnings Summary Revolution Medicines posted Q1 2025 earnings on May 7, 2025, reporting an EPS of -$1.13, which missed analysts' consensus estimates of -$1.12 by $0.01. With a trailing EPS of -$4.00, Revolution Medicines' earnings are expected to decrease next year, from ($3.49) to ($3.99) per share. Upcoming Q2 Earnings DateAug. 6After Market ClosesEstimatedConsensus EPS (May. 7) -$1.12 Actual EPS (May. 7) -$1.13 Missed By -$0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)RVMD Upcoming EarningsRevolution Medicines' Q2 2025 earnings is scheduled for Wednesday, August 6, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get Revolution Medicines Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Revolution Medicines and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRVMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RVMD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Revolution Medicines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.09-$0.89-$0.99Q2 20253-$1.17-$1.06-$1.13Q3 20253-$1.19$0.12-$0.71Q4 20253-$1.23-$1.08-$1.18 FY 2025 11 -$4.68 -$2.91 -$4.01 Q1 20262-$1.27-$1.26-$1.27Q2 20262-$1.29-$1.24-$1.27Q3 20262-$1.33-$1.24-$1.29Q4 20262-$1.36-$1.27-$1.32 Revolution Medicines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)-------5/7/2025Q1 2025-$1.12-$1.13 -$0.01-$1.13--2/26/2025Q4 2024-$1.01-$1.12 -$0.11-$1.12$0.35M-11/6/2024Q3 2024-$0.89-$0.94 -$0.05-$0.94$0.35M-8/7/2024Q2 2024-$0.77-$0.81 -$0.04-$0.81$0.81M$1.00M5/8/2024Q1 2024-$0.75-$0.70+$0.05-$0.70$1.37M-2/26/2024Q4 2023-$0.85-$1.14 -$0.29-$1.14$1.20M$0.74M11/6/2023Q3 2023-$1.01-$0.99+$0.02-$0.99$0.75M-8/8/2023Q2 2023-$0.82-$0.92 -$0.10-$0.92$1.56M$3.82M Revolution Medicines Earnings - Frequently Asked Questions When is Revolution Medicines' earnings date? Revolution Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on RVMD's earnings history. Did Revolution Medicines beat their earnings estimates last quarter? In the previous quarter, Revolution Medicines (NASDAQ:RVMD) missed the analysts' consensus estimate of ($1.12) by $0.01 with a reported earnings per share (EPS) of ($1.13). Learn more on analysts' earnings estimate vs. RVMD's actual earnings. How can I listen to Revolution Medicines' earnings conference call? The conference call for Revolution Medicines' latest earnings report can be listened to online. Listen to Conference Call How can I read Revolution Medicines' conference call transcript? The conference call transcript for Revolution Medicines' latest earnings report can be read online. Read Transcript How much revenue does Revolution Medicines generate each year? Revolution Medicines (NASDAQ:RVMD) has a recorded annual revenue of $11.58 million. How much profit does Revolution Medicines generate each year? Revolution Medicines (NASDAQ:RVMD) has a recorded net income of -$600.09 million. RVMD has generated -$4.00 earnings per share over the last four quarters. What is Revolution Medicines' EPS forecast for next year? Revolution Medicines' earnings are expected to decrease from ($3.49) per share to ($3.99) per share in the next year. More Earnings Resources from MarketBeat Related Companies ONC Earnings Results BNTX Earnings Results TEVA Earnings Results INSM Earnings Results SMMT Earnings Results ITCI Earnings Results GMAB Earnings Results RDY Earnings Results MRNA Earnings Results VTRS Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft Earnings3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor Hopes This page (NASDAQ:RVMD) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVMD Stock Alerts